AD Genetic Risk Factors and Tau Spreading

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2015 Jun 9

PMID 26052285

Citations 12

Authors

Jesus Avila

Alberto Gomez-Ramos

Marta Bolos

Affiliations

Soon will be listed here.

Citing Articles

APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial.

Zeng Y, Du W, Zhang M, Walker A, Han Y, Ding Y Brain Sci. 2024; 14(3).

PMID: 38539669 PMC: 10969297. DOI: 10.3390/brainsci14030281.

AD-Syn-Net: systematic identification of Alzheimer's disease-associated mutation and co-mutation vulnerabilities via deep learning.

Pan X, Coban Akdemir Z, Gao R, Jiang X, Sheynkman G, Wu E Brief Bioinform. 2023; 24(2).

PMID: 36752347 PMC: 10025433. DOI: 10.1093/bib/bbad030.

A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes.

Wang X, Broce I, Qiu Y, Deters K, Fan C, Dale A Alzheimers Dement. 2023; 19(7):3078-3086.

PMID: 36701211 PMC: 10368787. DOI: 10.1002/alz.12952.

Advancing combination therapy for Alzheimer's disease.

Salloway S, Sevingy J, Budur K, Pederson J, DeMattos R, von Rosenstiel P Alzheimers Dement (N Y). 2020; 6(1):e12073.

PMID: 33043108 PMC: 7539671. DOI: 10.1002/trc2.12073.

Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.

Jayaraj R, Azimullah S, Beiram R Saudi J Biol Sci. 2020; 27(2):736-750.

PMID: 32210695 PMC: 6997863. DOI: 10.1016/j.sjbs.2019.12.028.

References

Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A . Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet. 2007; 16(8):865-73. DOI: 10.1093/hmg/ddm031. View

Pineda-Lucena A, Ho C, Mao D, Sheng Y, Laister R, Muhandiram R . A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. J Mol Biol. 2005; 351(1):182-94. DOI: 10.1016/j.jmb.2005.05.046. View

Liu L, Drouet V, Wu J, Witter M, Small S, Clelland C . Trans-synaptic spread of tau pathology in vivo. PLoS One. 2012; 7(2):e31302. PMC: 3270029. DOI: 10.1371/journal.pone.0031302. View

Ren G, Vajjhala P, Lee J, Winsor B, Munn A . The BAR domain proteins: molding membranes in fission, fusion, and phagy. Microbiol Mol Biol Rev. 2006; 70(1):37-120. PMC: 1393252. DOI: 10.1128/MMBR.70.1.37-120.2006. View

Strittmatter W, Saunders A, Goedert M, Weisgraber K, Dong L, Jakes R . Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A. 1994; 91(23):11183-6. PMC: 45191. DOI: 10.1073/pnas.91.23.11183. View

Maeda Y, Tsutsui K, Seki S, Tokunaga A . cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. Biochem Biophys Res Commun. 1997; 236(1):178-83. DOI: 10.1006/bbrc.1997.6927. View

Sakamuro D, Zhang J, Duhadaway J, Prendergast G . Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem. 1998; 272(50):31453-8. DOI: 10.1074/jbc.272.50.31453. View

Pankhurst G, Bennett C . Characterization of the heparin-binding properties of human clusterin. Biochemistry. 1998; 37(14):4823-30. DOI: 10.1021/bi972367v. View

Saito Y, Ruberu N, Sawabe M, Arai T, Tanaka N, Kakuta Y . Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol. 2004; 63(9):911-8. DOI: 10.1093/jnen/63.9.911. View

10.

Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger J, Zerbinatti C . Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease. PLoS One. 2014; 9(7):e103187. PMC: 4106906. DOI: 10.1371/journal.pone.0103187. View

11.

Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen K . Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013; 18(11):1225-34. PMC: 3807661. DOI: 10.1038/mp.2013.1. View

12.

Pooler A, Phillips E, Lau D, Noble W, Hanger D . Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 2013; 14(4):389-94. PMC: 3615658. DOI: 10.1038/embor.2013.15. View

13.

Rubinsztein D . The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006; 443(7113):780-6. DOI: 10.1038/nature05291. View

14.

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

15.

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere M . Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009; 41(10):1088-93. PMC: 2845877. DOI: 10.1038/ng.440. View

16.

Bertrand P, Poirier J, Oda T, Finch C, Pasinetti G . Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res. 1995; 33(1):174-8. DOI: 10.1016/0169-328x(95)00097-c. View

17.

Schellenberg G, Montine T . The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol. 2012; 124(3):305-23. PMC: 3708460. DOI: 10.1007/s00401-012-0996-2. View

18.

Tan M, Yu J, Tan L . Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease. Trends Mol Med. 2013; 19(10):594-603. DOI: 10.1016/j.molmed.2013.06.004. View

19.

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J, Carrasquillo M . Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011; 43(5):429-35. PMC: 3084173. DOI: 10.1038/ng.803. View

20.

Lambert J, Heath S, Even G, Campion D, Sleegers K, Hiltunen M . Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009; 41(10):1094-9. DOI: 10.1038/ng.439. View